BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
March 28, 2007
View Archived Issues
Algeta Grosses $41M In IPO To Advance Alpharadin Trials
Algeta ASA's IPO on the Oslo Stock Exchange hit the upper end of its target, raising gross proceeds of slightly less than NOK250 million (US$41.1 million). (BioWorld International)
Read More
VASTox On Buying Spree; Next Item: A New Identity
Read More
Gene Related to Biological Clock Also Has Role in DNA Repair
Read More
TiGenix Stocks Gobbled Up As Belgian Biotechs Soar
Read More
Clinuvel Adds New Indication For Tanner Turned Compound
Read More
EU OKs Three GM Products But Withdraws Five Others
Read More
Other News To Note
Read More
ProFibrix Raises $11M For User-Friendly Fibrinogen
Read More